AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$38.67
−$0.34 (−0.86%) 12:59 PM ET
Prev closePrevC$39.00
OpenOpen$38.91
Day highHigh$39.38
Day lowLow$38.65
VolumeVol1,871,196
Avg volAvgVol6,759,224
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$19.18B
P/E ratio
-2.84
FY Revenue
$196.35B
EPS
-13.62
Gross Margin
19.68%
Sector
Healthcare
AI report sections
MIXED
CNC
Centene Corporation
Centene’s share price shows firm short- to medium-term upside momentum after a steep 12‑month drawdown, with the stock trading above key moving averages and near recent breakout levels. Fundamentals present a mixed picture, combining large-scale revenue with positive free cash flow but also negative margins and sharply deteriorated earnings. Technical patterns and moderate short interest indicate improving sentiment while profitability pressure and earnings volatility remain central risks.
AI summarized at 12:29 PM ET, 2026-01-02
AI summary scores
INTRADAY:68SWING:72LONG:43
Volume vs average
Intraday (cumulative)
+14% (Above avg)
Vol/Avg: 1.14×
RSI
61.11(Strong)
Strong (60–70)
0255075100
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.03 Signal: -0.02
Short-Term
+0.74 (Strong)
MACD: 0.02 Signal: -0.72
Long-Term
+0.65 (Strong)
MACD: -1.61 Signal: -2.26
Intraday trend score
66.42
LOW57.42HIGH76.42
Latest news
CNC•12 articles•Positive: 2Neutral: 5Negative: 5
NeutralBenzinga• Vandana Singh
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments
The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.
UNHHUMCVSELVMedicare AdvantageCMS payment rates2027 capitation ratesrisk adjustment model
Sentiment note
Stock edged up only 0.48%, suggesting minimal market reaction despite the positive Medicare Advantage payment news
NegativeBenzinga• Nabaparna Bhattacharya
Centene, Paramount Skydance, And Ulta Beauty Are Among Top 10 Large Cap Losers Last Week (March 9-March 13): Are the Others in Your Portfolio?
Ten large-cap stocks experienced significant declines during the week of March 9-13, 2026. Fair Isaac Corporation led losses with a 21.59% drop following a $1 billion senior notes offering announcement. Other major decliners included Centene (20.85%), Ulta Beauty (16.04%), Paramount Skydance (15.4%), and Thomson Reuters (13.97%). Declines were attributed to factors including disappointing earnings guidance, analyst downgrades, and broader market pressures across healthcare, beauty, media, and aviation sectors.
U.S. stocks rallied Tuesday as crude oil plummeted 10% to $85/barrel following President Trump's signals that the Iran conflict may be ending soon and his commitment to keep the Strait of Hormuz safe. The S&P 500 rose 0.3%, Dow gained 0.4%, and Nasdaq 100 advanced 0.5%, while the VIX dropped 9.3% signaling reduced market fear.
Healthcare Transportation Service Report 2026-2035: A $155.25+ Billion Market by 2030 with Centene, Molina Healthcare, DHL, ARAMARK, Lyft Healthcare, and ModivCare Leading
The healthcare transportation service market is expected to grow from $116.47 billion in 2026 to $155.26 billion by 2030, with a CAGR of 7.5%. Growth drivers include aging populations, chronic disease prevalence, home healthcare expansion, and AI-powered route optimization. Leading companies include Centene, Molina Healthcare, DHL, ARAMARK, Lyft Healthcare, and ModivCare, with North America currently dominant and Asia-Pacific showing fastest growth.
CNCMOHARMKhealthcare transportationmedical transportpatient transportnon-emergency medical transportationAI-powered route optimization
Sentiment note
Listed as a leading company in the growing healthcare transportation service market, positioned to benefit from projected 7.5% CAGR growth through 2030.
NegativeBenzinga• Vandana Singh
Centene Takes A Hit As Medicaid Membership Shrinks
Centene Corporation reported mixed fourth-quarter 2025 results with revenue beating expectations at $49.73 billion, but the stock fell 5.87% due to a weak 2026 outlook. The company faced challenges from declining Medicaid membership (down to 12.52 million from 13.00 million) and a higher health benefits ratio of 94.3%, though it expects adjusted EPS above $3.00 for 2026.
Stock declined 5.87% despite beating revenue expectations. The decline was driven by shrinking Medicaid membership, elevated health benefits ratio (94.3%, up from 89.6%), and lower 2026 sales guidance ($186.5B-$190.5B vs. consensus $193.43B), indicating operational challenges and margin pressures despite positive EPS guidance.
NeutralInvesting.com• Timothy Fries
Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum
Philip Morris International significantly exceeded earnings expectations with EPS of $7.54 vs. $1.70 expected and revenue of $10.4B vs. $10.39B expected, driven by strong growth in smoke-free products. Biogen also beat estimates with EPS of $1.99 vs. $1.61 expected, boosted by strong sales of LEQEMBI and SKYCLARYS. Centene reported mixed results but beat both EPS and revenue expectations. All three companies provided positive 2026 guidance.
Reported mixed results with EPS beat (-$1.19 vs -$1.22 expected) and revenue beat ($49.73B vs $48.39B expected), but faced a challenging year. However, strategic initiatives showing positive results with 2026 guidance of adjusted diluted EPS greater than $3.00.
NegativeBenzinga• Vandana Singh
Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling
The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage payment increase of only 0.09%, significantly below Wall Street's expectations of 4-6%. This modest growth announcement triggered sharp declines in major health insurer stocks, with UnitedHealth, Humana, and CVS Health leading the losses. The CMS emphasized program sustainability and payment accuracy through updated risk adjustment models.
Stock declined 7.26% as the lower-than-expected payment increase affects Medicaid and Medicare Advantage revenue streams.
NeutralBenzinga• Chandrima Sanyal
From Nio To Baidu: Themes Supercharges Trading With 7 New 2X Single-Stock ETFs
Leverage Shares by Themes launched seven new 2X leveraged single-stock ETFs on December 18, 2025, offering 200% daily performance exposure to stocks including Nio, Snap, Baidu, Centene, KLA, Petrobras, and Vale. These products carry a 0.75% expense ratio and are designed for short-term traders rather than long-term investors. The expansion brings Leverage Shares' total single-stock daily leveraged ETF offerings to 60.
Centene is included in the new ETF launch as an underlying asset with no company-specific news or developments mentioned.
NegativeBenzinga• Vandana Singh
Cigna Offers Cleaner Growth Than Other Health Insurers, Says Analyst
BofA Securities highlighted Cigna's strong potential in commercial health insurance, noting its pharmacy benefit management platform and ability to deliver 10-15% annual EPS growth, while also discussing challenges and opportunities in the healthcare insurance market.
Facing challenges with Medicaid enrollment declines, uncertain exchange risk pricing, and limited near-term market reward potential
PositiveThe Motley Fool• Matthew Benjamin
Forget CVS, Buy This Healthcare Stock Instead
Centene, a healthcare insurance company managing government-sponsored health programs, could see stock gains if ACA subsidies are extended in December. The stock has rebounded after a significant drop in July and shows potential for growth.
Stock has rebounded almost 19% in the past month, beat earnings expectations, lowered medical costs, and could benefit from potential ACA subsidy extensions
NeutralBenzinga• Vandana Singh
White House Set To Unveil Framework To Extend Obamacare Subsidies
The White House is preparing to introduce a healthcare framework to extend Affordable Care Act subsidies, proposing a two-year extension with updated eligibility limits and measures to control premium increases affecting approximately 22 million Americans.
Healthcare policy framework could create uncertainty in insurance sector
NeutralBenzinga• Prnewswire
Canada Nickel Announces the Referral of the Company's Crawford Project to the Major Projects Office by the Government of Canada
Canada Nickel's Crawford Nickel Project has been referred to the Major Projects Office by the Canadian government, highlighting its strategic importance for critical minerals and clean energy development. The project is expected to generate significant economic impact and contribute to Canada's low-carbon economy goals.
No direct involvement in the article's main content; mentioned only in stock listing information
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal